May 5, 2021Open Access

Retinal Fluid and Thickness as Measures of Disease Activity in Neovascular Age-Related Macular Degeneration

Key Points

Key points are not available for this paper at this time.

Abstract

Retinal thickness and retinal fluid are common anatomical measures of disease activity in neovascular age-related macular degeneration. Further research is required to fully elucidate the relationship between anatomical features and visual outcomes in neovascular age-related macular degeneration.

Read Full Paperexternally

KI fragen

Bookmark

View Full Paper

Cite This Study

Kaiser et al. (Wed,) studied this question.

synapsesocial.com/papers/69debe8540ea065679559536 https://doi.org/https://doi.org/10.1097/iae.0000000000003194

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1A comparison of the therapeutic response between brolucizumab and aflibercept in the HAWK & HARRIER trials using deep learning-based OCT analysis2020 · 5 citations
2An Optical Coherence Tomography-Guided, Variable Dosing Regimen with Intravitreal Ranibizumab (Lucentis) for Neovascular Age-related Macular Degeneration2007 · 972 citations
3Morphologic Parameters Relevant for Visual Outcome During Anti-Angiogenic Therapy of Neovascular Age-Related Macular Degeneration2014 · 184 citations
4HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration2019 · 921 citations

KI fragen

Bookmark

View Full Paper